Top Markets
#1 Cortex Cortex +33.88%
#2 Seeker Seeker +17.50%
#3 Official Trump Official Trump +9.41%
#4 EXOD EXOD +9.04%
#5 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +7.86%
#6 TDCCP TDCCP +5.78%
#7 aelf aelf +5.06%
#8 Fake World Assets Fake World Assets +4.68%
#9 Melania Meme Melania Meme +4.33%
#10 Solstice Solstice +4.12%
Coin of the day
Cortex Cortex
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Damora Therapeutics, Inc. Damora Therapeutics, Inc.

Damora Therapeutics, Inc.

DMRA
Rangering i aksjer #6695
Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering... Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye, its corporate operations are based in Boston, Massachusetts.
Aksjekurs
$30.90
Sist synkronisert: 2026-08-27
Markedsverdi
$1.90B
Endring (1 dag)
1.68%
Endring (1 år)
859.63%
Land
US
Handel Damora Therapeutics, Inc. (DMRA)

Kategori

Healthcare
EPS for Damora Therapeutics, Inc. (DMRA)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Damora Therapeutics, Inc. er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Damora Therapeutics, Inc. fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH